Concise review pre leukaemia stem cells molecular biology and clinical implications of the precursor to leukaemia stem cells

Author(s): Pandolfi A, Barreyro L, Steid U


Recent experimental evidence has shown that acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) arise from transformed immature hematopoietic cells following the accumulation of multiple stepwise genetic and epigenetic changes in hematopoietic stem cells and committed progenitors. The series of transforming events initially gives rise to preleukemic stem cells (pre-LSC), preceding the formation of fully transformed leukemia stem cells (LSC). Despite the established use of poly-chemotherapy, relapse continues to be the most common cause of death in AML and MDS. The therapeutic elimination of all LSC, as well as pre-LSC, which provide a silent reservoir for the re-formation of LSC, will be essential for achieving lasting cures. Conventional sequencing and next-generation genome sequencing have allowed us to describe many of the recurrent mutations in the bulk cell populations in AML and MDS, and recent work has also focused on identifying the initial molecular changes contributing to leukemogenesis. Here we review recent and ongoing advances in understanding the roles of pre-LSC, and the aberrations that lead to pre-LSC formation and subsequent LSC transformation.

Similar Articles

Revision of the World Health Organization classification of lymphoid neoplasms

Author(s): Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, et al.

US lymphoid malignancy statistics by World Health Organization Subtypes

Author(s): Teras LR, DeSantis EC, Cerhan JR, Morton LM, Flowers CR, et al.

Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immune histo-chemical profile

Author(s): Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, et al.

Follicular Lymphoma International Prognostic Index 2: A new prognostic index for Follicular Lymphoma Prognostic Factor Project

Author(s): Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, et al.

Long term remission of patients with follicular lymphoma grade 3 treated with R CHOP

Author(s): Strati P, Fowler N, Pina-Oviedo S, Medeiros LJ, Overman MJ, et al.